Black Diamond Therapeutics, Inc.

Black Diamond Therapeutics, Inc.verified

BDTX

Price:

$2.19

Market Cap:

$123.92M

Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 driver mutations. The company is also developing BDTX-1535, a brain-penetrant inhibitor of EGFR mutations, including canonical, intrinsic resistance, and acquired resistance mutations; and BDTX-4933, a brain-penetrant inhibitor of oncogenic BRAF class I, II and III alterations. It has a strategic partnership with OpenEye ...[Read more]

Industry

Biotechnology

IPO Date

2020-01-31

Stock Exchange

NASDAQ

Ticker

BDTX

The Enterprise Value as of December 2024 (TTM) for Black Diamond Therapeutics, Inc. (BDTX) is 123.50M

According to Black Diamond Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 123.50M. This represents a change of -42.85% compared to the average of 216.08M of the last 4 quarters.

Black Diamond Therapeutics, Inc. (BDTX) Historical Enterprise Value (quarterly & annually)

How has BDTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Black Diamond Therapeutics, Inc. over the last ten years is 521.20M. The current 123.50M Enterprise Value has changed 2.27% with respect to the historical average. Over the past ten years (40 quarters), BDTX's Enterprise Value was at its highest in in the June 2020 quarter at 1.45B. The Enterprise Value was at its lowest in in the March 2018 quarter at 0.

Quarterly (TTM)
Annual

Average

521.20M

Median

288.67M

Minimum

59.21M

Maximum

1.46B

Black Diamond Therapeutics, Inc. (BDTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Black Diamond Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 161.42%

Maximum Annual Enterprise Value = 1.46B

Minimum Annual Increase = -84.88%

Minimum Annual Enterprise Value = 59.21M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202392.59M56.37%
202259.21M-61.93%
2021155.55M-84.88%
20201.03B-29.71%
20191.46B161.42%
2018559.90M93.96%

Black Diamond Therapeutics, Inc. (BDTX) Average Enterprise Value

How has BDTX Enterprise Value performed in the past?

The current Enterprise Value of Black Diamond Therapeutics, Inc. (BDTX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

102.45M

5-year avg

559.96M

10-year avg

521.20M

Black Diamond Therapeutics, Inc. (BDTX) Enterprise Value vs. Peers

How is BDTX’s Enterprise Value compared to its peers?

Black Diamond Therapeutics, Inc.’s Enterprise Value is less than Passage Bio, Inc. (0), greater than TCR2 Therapeutics Inc. (33.56M), greater than Harpoon Therapeutics, Inc. (79.12M), less than Alector, Inc. (861.85M), less than Revolution Medicines, Inc. (185.51M), less than Atreca, Inc. (7.90B), greater than Stoke Therapeutics, Inc. (-8620212.00), less than Homology Medicines, Inc. (467.23M), greater than Adaptimmune Therapeutics plc (-103303255.00), greater than null (58.35M),

Build a custom stock screener for Black Diamond Therapeutics, Inc. (BDTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Black Diamond Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Black Diamond Therapeutics, Inc. (BDTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Black Diamond Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Black Diamond Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Black Diamond Therapeutics, Inc. (BDTX)?

What is the 3-year average Enterprise Value for Black Diamond Therapeutics, Inc. (BDTX)?

What is the 5-year average Enterprise Value for Black Diamond Therapeutics, Inc. (BDTX)?

How does the current Enterprise Value for Black Diamond Therapeutics, Inc. (BDTX) compare to its historical average?